Acumen Pharmaceuticals's total assets for Q1 2025 were $204.48M, a decrease of -14.44% from the previous quarter. ABOS total liabilities were $48.96M for the fiscal quarter, a -14.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.